Tony Berberabe, M.P.H.

January 25, 2023

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

December 10, 2021

The use of pyrotinib — an experimental drug — plus the chemotherapy capecitabine extended survival compared with Tykerb and capecitabine among patients with pretreated HER2-positive metastatic breast cancer.

May 23, 2018

The group came together to discuss gaps in knowledge concerning the prostate cancer journey, including nonmetastatic castration-resistant prostate cancer (nmCRPC) and metastatic disease.

February 10, 2017

Axicabtagene ciloleucel can lead to complete remission for patients with refractory diffuse large B-cell lymphoma, according to a recent study.

October 24, 2016

Three treatment options for localized prostate cancer all showed a similar low prostate-specific mortality rate.

October 17, 2016

A computer simulation tool may help plan treatment for certain patients with recurrent glioblastoma.

October 12, 2016

Choosing active surveillance did not increase stress levels for men with low-risk prostate cancer, according to a recent study.

June 23, 2016

Researchers are hopeful about the potential for a novel agent in high-risk prostate cancer.

June 14, 2016

Temozolomide may have survival benefits for certain patients with brain cancer, according to a recent study.

June 06, 2016

Tecentriq is showing reduction in tumor size for patients with metastatic urothelial carcinoma, according to a phase 2 study.

February 22, 2016

August 08, 2015

New diagnoses of prostate cancer have declined nearly 30 percent, a study has found, since the U.S. Preventive Services Task Force discouraged the routine use of prostate-specific antigen testing in 2011.

June 05, 2015

Adding the chemotherapy docetaxel to standard combination hormonal and radiation therapy boosted survival rates in patients with high-risk localized prostate cancer, according to a study.

May 21, 2015

The combination of multiparametric MRI with a fusion-guided biopsy (MRI plus ultrasound) was more effective at detecting aggressive prostate cancer compared with either procedure alone.

May 19, 2015

Although use of robotic surgery for prostate cancer has surpassed open surgical procedures in number, the impact of this approach on patient quality of life has not been well-studied.

April 03, 2015

Treatment with Xtandi reduced the risk of progression by 76 percent compared with bicalutamide in men with castration-resistant prostate cancer, according to topline results from the phase 2 STRIVE study.

March 24, 2015

Two studies investigating Xtandi in men with early-stage metastatic castration-resistant prostate cancer (mCRPC) further confirmed the overall survival (OS) and progression-free survival (PFS) benefit of the agent over placebo, according to two recent studies.

March 16, 2015

The continuing contentious debate about screening for prostate cancer remains top of mind among the public and lay press.

February 16, 2015

ASCO has endorsed new prostate cancer survivorship care guidelines from the American Cancer Society that provide a structure to help prostate cancer patients with localized disease to receive high quality care from specialists and primary care physicians.